Abstract
The epidemic of cardiovascular disease especially coronary heart disease (CHD) is emerging in rural India and accelerating in urban India. Coronary heart disease is the leading cause of death in India; diabetes accounts for a significant burden of CHD events. Trimetazidine (TMZ) is a piperazine derivative with anti-ischaemic properties. It is the first in a new class of metabolic agent, available for clinical use.: To determine the effect of TMZ on blood parameters in normal, hyperlipidemic, diabetic and Streptozotocin induced diabetic hyperlipidemic rats. Adult male albino rats of Wistar strain, weighing approximately 150 to 180 g, were used in the present study. After various treatments, blood was collected from the rats by sinocular puncture for the blood parameters like Fasting blood glucose, urine sugar, HbA1c and Haemoglobin with standard protocols.The levels of blood glucose, HbA1c and urine sugar were found to be elevated in the entire diseased control group than normal control.TMZ has the potential effect against the STZ induced syndromes with an optimum dose of 40 mg/kg in rats.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Clinical Biochemistry and Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
